Completed Research Support

  1. Cancer Prevention and Research Institute of Texas, High-Impact High-Risk
    PI: Holder
    $200000, 8/31/2018-8/30/2020
    Nanoparticle-Mediated Hyperthermia to Improve Chemotherapeutic Efficacy in HIPEC for Gastric Cancer
  2. Houston Methodist Translational Research Initiative
    PI: Holder
    $564,501, 05/01/2019-07/31/2020
    Gold Nanorod-Mediated Hyperthermia to Improve Chemotherapeutic Efficacy in HIPEC
  3. Houston Methodist SPG Performance Grant
    PI: Holder
    $39,084, 01/01/2019-12/31/2019
    The Impact of Lymphatic Transport Kinetics on Metastatic Potential in Melanoma
  4. Houston Methodist SPG Performance Grant
    PI: Esnaola; Co-I: Holder
    $40,000, 01/01/2019-12/31/2019
    Neoadjuvant Immunotherapy for Patients with Cutaneous Melanoma and Occult Nodal Metastases
  5. Weill Cornell Medicine/Houston Methodist Mentored Clinical Research Training Program
    PI: Holder/Esnaola
    $29,000, 8/1/2018-8/1/2019
    Neoadjuvant Checkpoint Inhibition for High-Risk Nonmetastatic Resectable Cutaneous Melanoma